An investigational oral selective orexin receptor 2 agonist significantly improved measures of wakefulness, sleepiness, and ...

Women with advanced breast cancer who progress on prior CDK4/6 inhibition can still benefit from second-line treatment with a CDK4/6 inhibitor as part of combination therapy.

Focusing magnetic resonance-guided focused ultrasound thalamotomy on a newly identified target in the brain could improve ...